Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 7/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CPA3 | P15088 | 2/20 | 0.59 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.59 |
| ▸ | ALPI | P09923 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | XIAP | P98170 | 1/20 | 0.57 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.57 |
| ▸ | CPA1 | P15085 | 4/20 | 0.56 |
| ▸ | ACE | P12821 | 2/20 | 0.56 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.56 |
| ▸ | CPB1 | P15086 | 1/20 | 0.53 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.53 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.52 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.52 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4838500 | 1.00 | MME (0.65) | MMECYP1A2CPA3FOLH1ALPI | |
| Hydrochloric Acid SCHEMBL7054010 | 0.98 | MME (0.62) | MMECYP1A2CPA3FOLH1ALPI | |
| SCHEMBL11213177 | 0.91 | MME (0.53) | MMECYP1A2CPA3FOLH1PTGS1 | |
| SCHEMBL3411005 | 0.84 | MME (0.58) | MMECYP1A2CPA3FOLH1ALPI | |
| SCHEMBL25432477 | 0.83 | EPHX1 (0.58) | MMECYP1A2CPA3FOLH1ALPI | |
| SCHEMBL1270436 | 0.83 | SLC7A5 (0.60) | MMESLC7A5CPA1ACEACE2 | |
| SCHEMBL9659004 | 0.83 | PPARG (0.56) | MME | |
| SCHEMBL2456064 | 0.83 | MME (0.56) | MMECYP1A2CPA3FOLH1ALPI | |
| SCHEMBL8240623 | 0.83 | EPHX1 (0.58) | MMECYP1A2CPA3FOLH1ALPI | |
| SCHEMBL5609028 | 0.83 | MME (0.56) | MMECYP1A2CPA3FOLH1ALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| US-20250027130-A1 | Nucleic Acid Synthesis and Sequencing Using Tethered Nucleoside Triphosphates | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-23 | — | — | US | disclosed |
| WO-2023164676-A1 | METHODS TO GENERATE NOVEL ACYL-TRNA SPECIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-08-31 | — | — | WO | disclosed |
| WO-2022224035-A2 | ANTI-GM1 ANTIBODY BINDING COMPOUNDS | POLYNEURON PHARMACEUTICALS AG (CH) | 2022-10-27 | — | — | WO | disclosed |
| CN-112592305-B | Organic compound and preparation method and application thereof | 中南大学 | 2022-10-18 | — | — | CN | disclosed |
| CN-114432181-A | Quick-acting eye cream | 玫琳凯有限公司 | 2022-05-06 | — | — | CN | disclosed |
| WO-2022082312-A1 | NOVEL CXCR4-TARGETING COMPOUNDS | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2022-04-28 | — | — | WO | disclosed |
| US-4625056-A | Process for producing benzene carboxylic acids from aromatic material utilizing an aliphatic organic acid agent | OCCIDENTAL RESEARCH CORPORATION (US) | 1986-11-25 | — | — | US | disclosed |
| EP-0193493-A2 | Tricyclic thieno derivatives, their preparation and pharmaceutical compositions containing them | Zyma SA (CH) | 1986-09-03 | — | — | EP | disclosed |
| US-4546136-A | Organotin-containing composition for the stabilization of polymers of vinyl chloride | AKZO N.V. (NL) | 1985-10-08 | — | — | US | disclosed |
| EP-0129264-A2 | Organotin-containing composition for the stabilization of polymers or copolymers of vinyl chloride | AKZO N.V. (NL) | 1984-12-27 | — | — | EP | disclosed |
| EP-0048159-A2 | Novel carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents | UNIVERSITY OF MIAMI (US) | 1982-03-24 | — | — | EP | disclosed |
| US-4248795-A | BY OXIDATION OF THE CORRESPONDING SULFIDE WITH AN AQUEOUS PERACID SOLUTION | UNION CARBIDE CORPORATION (US) | 1981-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | MME 1786/4885CYP1A2 1066/4885CPA3 871/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | MME 2323/4885CYP1A2 968/4885CPA3 2300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.